Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Pharm Res
2003 Sep 01;209:1389-93. doi: 10.1023/a:1025797808703.
Show Gene links
Show Anatomy links
Inhibitory effect of zinc on PEPT1-mediated transport of glycylsarcosine and beta-lactam antibiotics in human intestinal cell line Caco-2.
Okamura M
,
Terada T
,
Katsura T
,
Saito H
,
Inui K
.
???displayArticle.abstract???
PURPOSE: The aim of this study was to examine the effects of zinc on the intestinal peptide transporters (PEPT1 and basolateral peptide transporter) and to elucidate the mechanism of the interactions.
METHODS: Caco-2 cells were pretreated with zinc, and the uptake studies were carried out.
RESULTS: Zinc treatment resulted in the inhibition of [14C]glycylsarcosine (Gly-Sar) uptake via PEPT1 in a concentration-dependent manner, whereas it showed moderate inhibitory effect on the basolateral peptide transporter. Zinc also inhibited the uptake of oral beta-lactam antibiotics such as ceftibuten and cephradine by PEPT1. Kinetic analysis showed that zinc treatment increased Km values without affecting Vmax values of the [14C]Gly-Sar uptake. The inhibition of [14C]Gly-Sar uptake induced by zinc was observed in the presence of an H+ gradient but not in the absence of an H+ gradient.
CONCLUSIONS: These results indicate that zinc is a competitive inhibitor of PEPT1. Zinc inhibited the PEPT1 function, possibly by interacting with histidine residues of PEPT1 that are part of an H+-binding site. These findings would provide important information for clinical, physiologic, and biochemical aspects of peptide transporters.
Balimane,
Direct evidence for peptide transporter (PepT1)-mediated uptake of a nonpeptide prodrug, valacyclovir.
1998, Pubmed,
Xenbase
Balimane,
Direct evidence for peptide transporter (PepT1)-mediated uptake of a nonpeptide prodrug, valacyclovir.
1998,
Pubmed
,
Xenbase
Bettger,
A critical physiological role of zinc in the structure and function of biomembranes.
1981,
Pubmed
Black,
Therapeutic and preventive effects of zinc on serious childhood infectious diseases in developing countries.
1998,
Pubmed
Büsselberg,
Mammalian voltage-activated calcium channel currents are blocked by Pb2+, Zn2+, and Al3+.
1994,
Pubmed
Choi,
Identification and mechanism of action of two histidine residues underlying high-affinity Zn2+ inhibition of the NMDA receptor.
1999,
Pubmed
,
Xenbase
Daniel,
Selective effect of zinc on uphill transport of oligopeptides into kidney brush border membrane vesicles.
1995,
Pubmed
Döring,
Delta-aminolevulinic acid transport by intestinal and renal peptide transporters and its physiological and clinical implications.
1998,
Pubmed
,
Xenbase
Fei,
Identification of the histidyl residue obligatory for the catalytic activity of the human H+/peptide cotransporters PEPT1 and PEPT2.
1997,
Pubmed
,
Xenbase
Irie,
Recognition and transport characteristics of nonpeptidic compounds by basolateral peptide transporter in Caco-2 cells.
2001,
Pubmed
Leibach,
Peptide transporters in the intestine and the kidney.
1996,
Pubmed
Mitrovic,
Zn(2+) inhibits the anion conductance of the glutamate transporter EEAT4.
2001,
Pubmed
Norregaard,
Structural probing of a microdomain in the dopamine transporter by engineering of artificial Zn2+ binding sites.
2000,
Pubmed
Osendarp,
Zinc supplementation during pregnancy and effects on growth and morbidity in low birthweight infants: a randomised placebo controlled trial.
2001,
Pubmed
Pan,
Differentiation- and protein kinase C-dependent regulation of alanine transport via system B.
1995,
Pubmed
Rodriguez Yoldi,
Effect of zinc on aminopeptidase N activity and L-threonine transport in rabbit jejunum.
1996,
Pubmed
Rodríguez-Yoldi,
Action of zinc on enzymatic digestion and intestinal transport of sugar in the rabbit.
1994,
Pubmed
Saito,
Dipeptide transporters in apical and basolateral membranes of the human intestinal cell line Caco-2.
1993,
Pubmed
Saito,
Cloning and characterization of a rat H+/peptide cotransporter mediating absorption of beta-lactam antibiotics in the intestine and kidney.
1995,
Pubmed
,
Xenbase
Saito,
Molecular cloning and tissue distribution of rat peptide transporter PEPT2.
1996,
Pubmed
,
Xenbase
Terada,
Identification of the histidine residues involved in substrate recognition by a rat H+/peptide cotransporter, PEPT1.
1996,
Pubmed
,
Xenbase
Terada,
Structural requirements for determining the substrate affinity of peptide transporters PEPT1 and PEPT2.
2000,
Pubmed
Terada,
Functional characteristics of basolateral peptide transporter in the human intestinal cell line Caco-2.
1999,
Pubmed
Terada,
Interaction of beta-lactam antibiotics with histidine residue of rat H+/peptide cotransporters, PEPT1 and PEPT2.
1998,
Pubmed
Theis,
Defining minimal structural features in substrates of the H(+)/peptide cotransporter PEPT2 using novel amino acid and dipeptide derivatives.
2002,
Pubmed
,
Xenbase
Vallee,
The biochemical basis of zinc physiology.
1993,
Pubmed
Walsh,
Zinc: health effects and research priorities for the 1990s.
1994,
Pubmed
Watkins,
Zinc inhibition of glucose uptake in brush border membrane vesicles from pig small intestine.
1989,
Pubmed
